Julia Maslovskaja
Inserm(FR)Rodin Therapeutics (United States)(US)Centre Hospitalier Saint-Denis(FR)University of Tartu(EE)
Publications by Year
Research Areas
COVID-19 Clinical Research Studies, SARS-CoV-2 and COVID-19 Research, Diabetes and associated disorders, Long-Term Effects of COVID-19
Most-Cited Works
- → Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths(2021)617 cited
- → The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies(2022)183 cited
- → The risk of COVID-19 death is much greater and age-dependent with type I IFN autoantibodies(2022)24 cited
- Autoantibodies neutralizing type I IFNs are present in similar to 4% of uninfected individuals over 70 years old and account for similar to 20% of COVID-19 deaths(2021)